Dyadic International Inc.

DYAI

Healthcare Biotechnology

Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.

Revenue
−61.4%
EPS
n/m
Free cash flow
n/m
Total debt
+0.80%

Quarter to September 2026, against a year earlier

0.33 0.02 −5.71%
Market cap
$14.0M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

Ratios over time Q4 FY25 to Q3 FY26

Returns on capital

ROIC was 0.0% in Q3 FY26, the highest of these four quarters.

ROEROIC
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
ROE−397.8%−2826.8%522.6%−47310.8%
ROIC0.0%0.0%0.0%0.0%

Debt

It holds more cash than debt: net debt is −0.18× a year’s EBITDA.

Net debt / EBITDA
Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Net debt / EBITDA2.7×2.3×0.8×−0.2×

Cash cycle, in days

Customers pay in 0 days and suppliers are paid in 219. Suppliers fund 219 days of working capital.

Cash cycleDays to pay suppliersDays to be paid
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Cash cycle−1−4133−219
Days to pay suppliers13413894219
Days to be paid133971270

Per share, from Q4 FY25

Since Q4 FY25, per share: revenue has fallen 14.9%.

RevenueBook value
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue1.0×1.1×1.1×0.9×
Book value1.0×−0.3×−1.7×−1.8×
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 13 Nov
P/E ratio

+8 more quarters

0.00 0.00 0.00 0.00
P/S ratio
9.92 7.84 8.63 5.46
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(17.32) (15.20) (18.04) (11.35)
P/B ratio
24.88 0.00 0.00 0.00
EV/Sales
8.78 7.45 8.72 5.58
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
(4.67) (4.87) (4.41) (2.41)
Current Ratio
2.68 2.42 1.65 1.69
Net Debt/EBITDA
2.29 0.78 (0.18) —
Debt/Equity
4.08 (12.35) (2.11) 0.00
Earnings Yield
(26.60%) (28.05%) (25.56%) (47.73%)
Free Cash Flow Yield
(18.96%) (19.52%) (22.91%) (42.42%)
Free Cash Flow per Share
(0.05) (0.05) (0.05) (0.04)
Book value per Share
0.04 (0.01) (0.07) (0.07)
Free Cash Flow
(1.77) (1.96) (1.82) (1.48)
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 13 Nov 2026